Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference18 articles.
1. Cost implications and complications of overtreatment of low-risk prostate cancer in the United States;Aizer;J Natl Compr Canc Netw,2015
2. Projections of the cost of cancer care in the United States, 2010-2020;Mariotto;J Natl Cancer Inst,2011
3. Cost of new technologies in prostate cancer treatment: systematic review of costs and cost effectiveness of robotic-assisted laparoscopic prostatectomy, intensity-modulated radiotherapy, and proton beam therapy [e-pub ahead of print];Schroeck;Eur Urol,2017
4. Regional cost variations of robot-assisted radical prostatectomy compared with open radical prostatectomy;Faiena;Clin Genitourin Cancer,2015
5. Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer;Pilon;J Med Econ,2016
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Radical prostatectomy readmissions: Causes, risk factors, national rates, & costs;Urologic Oncology: Seminars and Original Investigations;2023-02
2. Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase;Urology;2021-09
3. Influence of pelvic lymph node dissection and node‐positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer;The Prostate;2020-10-19
4. Pelvic lymph node dissection at robot-assisted radical prostatectomy: Assessing utilization and nodal metastases within a statewide quality improvement consortium;Urologic Oncology: Seminars and Original Investigations;2020-04
5. Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2019-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3